| Health Performance Systems Llc | |
|
20 Towne Dr Ste 102, Bluffton, SC 29910 | |
| (843) 441-9208 | |
| Not Available |
| Full Name | Health Performance Systems Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 20 Towne Dr Ste 102, Bluffton, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437647070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| 133V00000X | Dietitian, Registered | (* (Not Available)) | Secondary |
| 225700000X | Massage Therapist | (* (Not Available)) | Secondary |
| Provider Name | Paul Martin Zorch |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1730179979 PECOS PAC ID: 9537144563 Enrollment ID: I20090728000315 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Melissa Wagner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336210798 PECOS PAC ID: 4587604244 Enrollment ID: I20100201000138 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Danielle Demerdjian |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831508480 PECOS PAC ID: 2860612702 Enrollment ID: I20140928000005 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Brittany Lee Brazill |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1306394424 PECOS PAC ID: 5799073128 Enrollment ID: I20170522001876 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Gregory S Keppel |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1497734032 PECOS PAC ID: 7719926575 Enrollment ID: I20181114001805 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Rachel Clark |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1780122531 PECOS PAC ID: 6305184649 Enrollment ID: I20190213000456 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Barbara Moschitta |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1932186418 PECOS PAC ID: 8224000302 Enrollment ID: I20191127001929 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Provider Name | Austin David Jones |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1891265534 PECOS PAC ID: 6305184375 Enrollment ID: I20200720001748 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Health Performance Systems Llc 55 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 Ph: (843) 540-3587 | Health Performance Systems Llc 20 Towne Dr Ste 102, Bluffton, SC 29910 Ph: (843) 441-9208 |
News Archive
The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Kaiser Health News staff writer Jordan Rau, working in collaboration with The Washington Post, reports on Provo, Utah: "If there is any place that should have medical spending under control, this is it" (Kaiser Health News).
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago
Dr. Anthony Nicholas Mattis, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1297 May River Rd, Suite 201, Bluffton, SC 29910 Phone: 843-815-2221 Fax: 843-815-2761 | |
Bluffton Family Chiropractic P A Chiropractor Medicare: Medicare Enrolled Practice Location: 80 Baylor Dr Ste 114, Bluffton, SC 29910 Phone: 843-706-3472 Fax: 843-706-3473 | |
Dr. John Charles Winnestaffer, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1 Sheridan Dr, Sheridan Park Ste E, Bluffton, SC 29910 Phone: 843-815-3400 Fax: 843-815-3402 | |
Carolina Chiropractic & Holistic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 25 Clark Summit Dr, Ste 103, Bluffton, SC 29910 Phone: 843-706-2847 Fax: 843-706-3743 | |
Dr. Taylor Paul, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 32 Wentworth Dr, Bluffton, SC 29910 Phone: 843-384-3236 | |
Hilton Head Chiropractic North Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1 Sheridan Dr, Sheridan Park Ste E, Bluffton, SC 29910 Phone: 843-815-3400 Fax: 843-815-3402 | |
Dr Bradley C Morris Dc Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 1127 Fording Island Rd # 102, Bluffton, SC 29910 Phone: 843-962-6855 |